Assessing the Value to the Patient of New Technologies in Anatomical Shoulder Arthroplasty
Dear CSS Colleagues:
I present to you an article that should be of great interest. It is entitled “Assessing the Value to the Patient of New Technologies in Anatomical Shoulder Arthroplasty.” In this article Dr. Matsen and colleagues have concluded there is little evidence that innovations in component design over the past 20 years have made any improvement in patient outcomes, and thus value. In fact, the incremental cost of these innovations may present a reduced value to many stakeholders in shoulder arthroplasty. I would be surprised if you didn’t have an opinion on this. I welcome input and would expect some meaningful discussion. I am withholding my comments so as not to prime or bias any of yours. Let our group know what you think about this conclusion.
Kind Regards,
JP Warner MD
Founder, CSS
Recent Posts
See AllDear Colleagues: Enclosed is an article which highlights the ongoing dilemma for Academic Medical Centers (AMCs) in an era of the value-based healthcare transformation. Most of you have already felt t
Dear Colleagues: Enclosed (YouTube | VuMedi) is a link to a presentation I gave as a visiting speaker in Riyadh, Saudi Arabia. This talk considers the management of the challenging category of patient
Dear colleagues: Enclosed (YouTube | VuMedi) is a lecture I gave about one month ago in Riyadh, Saudi Arabia at King Faisal Specialty Hospital. Here I consider the potential of digital tools to disrup
